$56.26
+0.650 (+1.17%)
At Close: Jun 23, 2026
ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics
07:00am, Tuesday, 29'th Oct 2024
ST. PAUL, Minn. , Oct. 29, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing and Bio-Techne Corporation (NASDAQ: TECH), today announced that Luminary Therapeutics has be
New career training option will help meet growing nationwide demand for Hyundai and Genesis automotive technicians. New career training option will help meet growing nationwide demand for Hyundai and
CYBER ENVIRO-TECH INC ANNOUNCES PARTNERSHIP WITH SOME OF ITS SHAREHOLDERS TO FOCUS ON THE LAUNDRY INDUSTRY
09:07am, Thursday, 10'th Oct 2024
SCOTTSDALE, Ariz. , Oct. 10, 2024 /PRNewswire/ -- Cyber Enviro-Tech Inc. (CETI) (OTCQB: CETI) CETI, is pleased to announce a partnership with its shareholder-based subsidiary, CETI Axenic (CAX), to pu
BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS
07:00am, Thursday, 10'th Oct 2024
MINNEAPOLIS , Oct. 10, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, October 30, 2024, at 8:00 a.m. C
ACAD or TECH: Which Is the Better Value Stock Right Now?
12:48pm, Wednesday, 09'th Oct 2024
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Acadia Pharmaceuticals (ACAD) and Techne (TECH). But which of these two stocks is more attractive to
ScaleReady announces a G-Rex® Grant has been awarded to LIfT Biosciences
07:00am, Wednesday, 09'th Oct 2024
Award will support clinical manufacturing of the Company's promising Neutrophil only Leukocyte Infusion Therapy (N-LIfT) platform ST. PAUL, Minn.
ST. PAUL, Minn. , Oct. 8, 2024 /PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that Eric Tran, P
ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. Klebanoff
07:00am, Monday, 07'th Oct 2024
ST. PAUL, Minn. , Oct. 7, 2024 /PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that Christopher
ALPHA PRO TECH, LTD. ANNOUNCES $1 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM FOR IMMEDIATE RELEASE
03:30pm, Wednesday, 02'nd Oct 2024
NOGALES, Ariz., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposa
LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
07:00am, Thursday, 26'th Sep 2024
MINNEAPOLIS , Sept. 26, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that one of its spatial biology brands, Lunaphore, is partnering with Discovery Life Sciences (Disco
BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
07:00am, Tuesday, 24'th Sep 2024
MINNEAPOLIS , Sept. 24, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its portfolio of solutions advancing neuroscience research at the upcoming annual me
BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
07:00am, Wednesday, 18'th Sep 2024
MINNEAPOLIS , Sept. 18, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today issued its 2024 Corporate Sustainability Report (CSR), detailing the continued progress advancing its Environme
ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape
07:00am, Wednesday, 18'th Sep 2024
ST. PAUL, Minn. , Sept. 18, 2024 /PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that ImmunoScap
ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics
07:00am, Tuesday, 17'th Sep 2024
ST. PAUL, Minn. , Sept. 17, 2024 /PRNewswire/ -- ScaleReadyTM, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReadyTM, today announced that it has awar
Verismo Therapeutics Awarded a ScaleReady™ G-Rex® Grant
07:00am, Tuesday, 17'th Sep 2024
PHILADELPHIA , Sept. 17, 2024 /PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR T company developing the novel KIR-CAR platform technology, today announced that it has been awarded a $150,00
Sign In
Buy TECH